| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6126104 | Transplant Immunology | 2011 | 6 Pages |
Abstract
These results imply that treatment with CD28 blockers and anti-CD25 mAbs may cooperate in promoting graft survival under conditions of low MHC matching where the donor-reactive T cell precursor frequency is high.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mandy L. Ford, Linda L. Stempora, Christian P. Larsen,